Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00002572
Recruitment Status : Completed
First Posted : July 29, 2004
Last Update Posted : May 30, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 1999
  Study Completion Date : December 1999